Context Historical Financial Ratios
| CNTX Stock | USD 1.39 0.05 3.47% |
Context Therapeutics is presently reporting on over 85 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 1.6 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Context Therapeutics financial condition quickly.
Context |
About Context Financial Ratios Analysis
Context TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Context Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Context financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Context Therapeutics history.
Context Therapeutics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Context Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Context Therapeutics sales, a figure that is much harder to manipulate than other Context Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Context Therapeutics dividend as a percentage of Context Therapeutics stock price. Context Therapeutics dividend yield is a measure of Context Therapeutics stock productivity, which can be interpreted as interest rate earned on an Context Therapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Operating Cash Flow Per Share
A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Tangible Asset Value
The total value of a company's physical, tangible assets, excluding intangible assets like patents and trademarks.Most ratios from Context Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Context Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.At this time, Context Therapeutics' Ebt Per Ebit is fairly stable compared to the past year. Effective Tax Rate is likely to rise to 0.05 in 2024, whereas Free Cash Flow Yield is likely to drop (1.22) in 2024.
| 2022 | 2023 | 2024 (projected) | Current Ratio | 11.8 | 3.83 | 5.21 | Net Debt To EBITDA | 2.39 | 0.58 | 0.55 |
Context Therapeutics fundamentals Correlations
Click cells to compare fundamentals
Context Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Context Stock Analysis
When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.